The synthesis and study of vasoactive properties of new 4-functionalized 1,3-oxazoles containing the N-methyl-D-glucamine fragment in position 5
DOI:
https://doi.org/10.24959/ophcj.17.921Keywords:
blood vessels, biologically active substances, N-methyl-D-glucamine, 4-functionalized 1, 3-oxazolesAbstract
The analysis of literature data shows the prospects of searching drugs with different biological activity among 1,3-oxazoles.
Aim. To develop preparative methods of the synthesis of new 4-fuctionalized 1,3-oxazoles containing the N-methyl-D-glucamine fragment in position 5 and to study their physical, chemical and biological properties.
Results and discussion. It has been found that 1,3-oxazoles reveal the vasodilatative and vasoconstrictive effect on the tonic activity of the vessels preactivated with phenylephrine depending on the concentration and the chemical structure of the compounds. The article describes the vasodilatative and vasoconstrictive efficacy of new 1,3-oxazoles compared to the known adrenolytic drug – amiodarone, and the inhibitor of potassium channels – 4-aminopyridine (pimadin).
Experimental part. A number of new 4-fuctionalized 1,3-oxazoles containing the N-methyl-D-glucamine fragment in position 5 was synthesized. Their biological activity was assessed under the action of selective agonists of 1-adrenoreceptors (phenylephrine), 5HT2A-receptor (serotonin) on the isolated segments of the rat’s aorta previously constricted or by blocking potassium channels with the high potassium Krebs solution.
Conclusions. It has been found that in the case of the serotonin constricted isolated aortic segments only the vasoconstriction is observed in contrast of the vessel activated with phenylephrine. If the constriction of the aortic segments is carried out with a high potassium solution, there is no vasotonic activity of 1,3-oxazole derivatives. The data obtained indicate the possible molecular mechanism of their biological activity with the participation of vascular adrenergic receptors and potassium channels, their inhibition may lead to vasodilatation at the comparatively high concentration of the compounds or vasoconstriction at the comparatively low concentration of oxazoles, respectively.
Downloads
References
- chung, S. C., Lee, S. H., Jang, K. H., Park, W., Jeon, J. E., Oh, H., Shin, J., Oh, K. B. (2011). Actin depolymerizing effect of trisoxazole–containing macrolides. Bioorganic & Medicinal Chemistry Letters, 21 (11), 3198–3201. doi: 10.1016/j.bmcl.2011.04.069
- Attaway, D. H., Zaborsky, O. R. (1993). Marine biotechnology: Pharmaceutical and bioactive natural products.New York: Springer science business media, 1, 318.
- Zhang, M. Z., Chen, Q., Xie, C. H., Mulholland, N., Turner, S., Irwin, D., Gu, Y. C., Yang, G. F., Clough, J. (2015). Synthesis and antifungal activity of novel streptochlorin analogues. European Journal of Medicinal Chemistry, 92, 776–783. doi: 10.1016/j.ejmech.2015.01.043
- Davis, A., Ward, S. E. (2015). The Handbook of Medicinal Chemistry: Principles and Practice. Royal society of chemistry, 1, 642.
- Casagrande, M., Barteselli, A., Basilico, N., Parapini, S., Taramelli, D., Sparatore, A. (2012). Synthesis and antiplasmodial activity of new heteroaryl derivatives of 7–chloro–4–aminoquinoline. Bioorganic & Medicinal Chemistry, 20 (19), 5965–5979. doi: 10.1016/j.bmc.2012.07.040
- Mussoni, L., Poggi, A., De Gaetano, G., Donati, M. B. Br. (1978). Growth and metastasis of the lewis lung carcinoma in mice defibrinated with batroxobin. European Journal of Cancer, 14 (4), 343–347. doi: 10.1016/0014–2964(78)90203–7
- Li, Z., Zhu, A., Yang, J. (2012). One–pot three–component mild synthesis of 2–aryl–3–(9–alkylcarbazol–3–yl)thiazolidin–4–ones. Journal of Heterocyclic Chemistry, 49 (6), 1458–1461. doi: 10.1002/jhet.1047
- Gupta, S., Yardley, V., Vishwakarma, P., Shivahare, R., Sharma, B., Launay, D., Martin, D., Sunil, K. Puri. (2015). Nitroimidazo–oxazole compound DNDI–VL–2098: an orally effective preclinical drug candidate for the treatment of visceral leishmaniasis. Journal of Antimicrobial Chemotherapy, 70 (2), 518–527. doi: 10.1093/jac/dku422
- Mulder, R. J., Shafer, C. M., Dalisay, D. S., Molinski, T. F. (2009). Synthesis and structure–activity relationships of bengazole A analogs. Bioorganic & Medicinal Chemistry Letters, 19 (11), 2928–2930. doi: 10.1016/j.bmcl.2009.04.069
- Zhong, Z., Zhang, D., Peng, Z., Li, Y., Shan, G., Zuo, L., Wu, L., Li, S., Gao, R., Li, Z. (2013). Synthesis and antiviral activity of a novel class of (5–oxazolyl)phenyl amines. European Journal of Medicinal Chemistry, 69, 32–43. doi: 10.1016/j.ejmech.2013.07.053
- Zhang, F., Chapman, K. T., Schleif, W. A., Olsen, D. B., Stahlhut, M., Rutkowski, C. A., Kuo, L. C., Jin, L., Lin, J. H., Emini, A., Tata, J. R. (2003). Comparative molecular field analysis (comfa) of phthalazine derivatives as phosphodiesterase iv inhibitors. Bioorganic & Medicinal Chemistry Letters, 13 (15), 2573–2576. doi: 10.1016/S0960–894X(03)00493–1
- Keaney, E. P., Connolly, M., Dobler, M., Karki, R., Honda, A., Sokup, S., Karur, S., Britt, S., Patnaik, A., Raman, P., Hamann, L. G., Wiedmann, B., Lamarche, M. J. (2014). 2–Alkyloxazoles as potent and selective PI4KIIIb inhibitors demonstrating inhibition of HCV replication. Bioorganic & Medicinal Chemistry Letters, 24 (16), 3714–3718. doi: 10.1016/j.bmcl.2014.07.015
- Lednicer, V. D., Mitscher, L. A. (1977). The organic chemistry of drug synthesis. New York–London: John Wiley and Sons, 1, 496.
- Greenblatt, D. J., Matlis, R., Scavone, J. M., Blyden, G. T., Harmatz, J. S., Shader, R. T. (1985). Oxaprozin pharmacokinetics in the elderly. British J. Clinical Pharmacology, 19 (3), 373–378. doi: 10.1111/j.1365–2125.1985.tb02656.x
- Shablykin, O. V., Kucharenko, O. P., Iakovenko, I. N., Yarmoluk, S. M., Brovarets, V. S. (2008). Search for specific protein kinase СК2 inhibitors and vasoactive compounds among 5–amino–1,3–oxazoles derivatives. Ukr. Bioorg. Acta, 6 (1), 28–36.
- Iakovenko, I. N., Shablykin, O. V., Kozachenko, O. P., Brovarets, V. S. (2012). Vasodilator effects of n–(2–aryl–4–thioсarbamoyl–1,3–oxazol–5–yl)–β–alanines as specific inhibitors of ck2 proteinkinase. Journal of Organic and Pharmaceutical Chemistry, 10 (3), 56–58.
- Iakovenko, I.N., Lukashuk, O.I., Kondratyuk, K.M., Golovchenko, A.V., Zhirnov, V.V., Brovarets, V.S. (2013). The synthesis and investigation of vasoactive properties of new phosphorylated peptidomimetics. Journal of Organic and Pharmaceutical Chemistry, 11 (3), 43–50.
- Abdurakhmanova, E.R., Lukashuk, E.I., Golovchenko, A.V., Pil’o, S.G., Brovarets, V.S. (2015). N–Methyl–D–glucamine–derived 4–substituted 1,3–oxazoles. Russian Journal of General Chemistry, 85 (4), 851–857. doi: 10.1134/S1070363215040143
- Kovalenko, A. L., Shigarova, L. V., Alekseeva, L. E. (2000). Farmatcia, 49 (1), 47–49.
- Roth, B.L., Nakaki, T., Chuang, D.M., Costa, E. (1986). 5–Hydroxytryptamine2 receptors coupled to phospholipase C in rat aorta: modulation of phosphoinositide turnover by phorbol ester. Journal of Pharmacology and Experimental Therapeutics, 238 (2), 480–485.
- Cote, P., Bourassa, M. G., Delaye, J., Janin, A., Froment, R., David, P. (1979). Effects of amiodarone on cardiac and coronary hemodynamics and on myocardial metabolism in patients with coronary artery disease. Circulation, 59 (6), 1165–1172.
- Mohort, N. A., Titovskaia, E. N. (2005). Eksperymentalna і klіnіchna meditsina, 2, 5–9.
- Maresova, L., Muend, S., Zhang, Y.Q., Sychrova, Y., Rao, R. (2009). Membrane hyperpolarization drives cation influx and fungicidal activity of amiodarone. Journal of Biological Chemistry, 284 (5), 2795–2802. doi: 10.1074/jbc.M806693200
- Belevych, A. E., Beck, R., Tammaro, P., Poston, L., Smirnov, S. V. (2002). Developmental changes in the functional characteristics and expression of voltage–gated K+ channel currents in rat aortic myocytes. Cardiovasc. Res., 54, 152–161.
- Drach, B. S., Sviridov, E. P., Kirilenko, A. A., Kirsanov, A. V. (1973). Zhurnal organicheskoi khimii, 9 (9), 1818–1824.
- Matsumura, K., Saraie, T., Hashimofo, N. (1972). ββ–Dichloro–α–aminoacrylonitrile. Journal of the Chemical Society, Chemical Communications, 12, 705–706. doi: 10.1039/C39720000705
- Drach, B. S., Miskevich, G. N. (1974). Zhurnal organicheskoi khimii, 10 (11), 2315–2319.
- Drach, B. S., Sviridov, E. P. (1973). Zhurnal organicheskoi khimii, 43 (7), 1648.
- Chervonnyi, V. A., Harchenko, A. V., Drach, B. S. (1988). Zhurnal organicheskoi khimii, 24 (2), 453.
- Kozachenko, A. P., Shablykin, O. V., Brovarets, V. S. (2012). Synthesis of 4–Alkyl–2–aryl–1,3–oxazole[5,4–d]pyrimidine–7(4Н)–thiones and 6–Alkyl–2–aryl–1,3–oxazole[5,4–d]pyrimidin–7(6Н)–ones from 2–Aroylamino–3,3–dichloroacrylonitriles. Russian Journal of General Chemistry, 82 (4), 739–743. doi:10.1134/S1070363212040226
- Kondratyuk, K., Lukashuk, O., Golovchenko, A., Komarov, I., Brovarets, V., Kukhar, V. (2013). Synthesis of 5–amino–2–aminoalkyl–1,3–oxazol–4–ylphosphonic acid derivatives and their use in the preparation of phosphorylated peptidomimetics. Tetrahedron, 69 (30), 6251–6161. doi: 10.1016/j.tet.2013.05.017
- Lukashuk, O., Kondratyuk, K., Golovchenko, A., Brovarets, V., Kukhar, V. (2013). A novel synthetic approach to phosphorylated peptidomimetics. Heteroatom Chem., 24 (4), 289–297. doi: 10.1002/hc.21093
- Drach, B. S., Sviridov, E. P. (1974). Zhurnal obshchei khimii, 44 (2), 348.
- Abdurahmanova, E. R., Lukashuk, E. I., Golovchenko, A. V., Brovarets, V. S. (2016). Synthesis and properties of 4–phosphorylated derivatives of 5–hydroxyalkylamino–1,3–oxazoles. Russian Journal of General Chemistry, 86 (7), 1584–1596. doi: 10.1134/S1070363216070094
- Sun, Y., Zhu, B., Browne, A. E., Sievers, R. E., Bekker, J. M., Chatterjee, K., Parmley, W. W., Glantz, S. A. (2001). Nicotine does not influence arterial lipid deposits in rabbits exposed to second–hand smoke. Circulation, 104 (7), 810–814. doi: 10.1161/hc3301.092788
- Orallo, F., Alvarez, E., Camina, M., Leiro, J. M., Gomez, E., Fernandez, P. (2002). The possible implication of trans–resveratrol in the cardioprotective effects of long–term moderate wine consumption. Mol. Pharmacol., 61 (2), 294–302. doi: 10.1124/mol.61.2.294
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2017 National University of Pharmacy
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors publishing their works in the Journal of Organic and Pharmaceutical Chemistry agree with the following terms:
1. Authors retain copyright and grant the journal the right of the first publication of the work under Creative Commons Attribution License allowing everyone to distribute and re-use the published material if proper citation of the original publication is given.
2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal’s published version of the work (e.g., post it to an institutional repository or publish it in a book) providing proper citation of the original publication.
3. Authors are permitted and encouraged to post their work online (e.g. in institutional repositories or on authors’ personal websites) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).